Alginate Market: Evolution
Alginate and alginate-based hydrogels have attracted enormous attention among industry players for their immense potential for biomedical applications. The biocompatible material has been extensively studied for applications in drug delivery vehicles in oncology and wound management, which has driven the rapid evolution of the alginate market.
The natural water-soluble polysaccharide is extracted various species of brown algae, including Laminaria digitata, Laminaria hyperborea, Laminaria japonica, Macrocystis pyrifera, and Ascophyllum nodosum. A number of alginate formulations are heading toward commercialization to meet the current and next-gen demands in the medical and healthcare industries.
The various technological advancements in bacterial biosynthesis have enabled producers of alginate constantly advance the physical and chemical properties of the final product, thereby broadening the canvas for players in the alginate market. The study strives to present an in-depth, data-driven model for assessing the key growth dynamics, promising avenues for R&D, and competitive dynamics shaping the forces of demand, supply, and the uptake trend in various consumer segments during the forecast period of 2021–2031.
Alginate Market: Drivers, Current Prospects, Lucrative Avenues
The alginate market is witnessing growth in sales from extensive utilization of alginate in meeting the needs for natural polymers in wide range of applications. The strides in the demand have been fueled by the growing pace of commercialization of functionalized polymers in the biomedical applications. Salient characteristics such as non-toxicity, remarkable biodegradability due to presence of polysaccharide with several unique physicochemical properties, and splendid biocompatibility with the biological system have spurred R&D by companies in the pharmaceutical and medical industries.
In particular, the alginate market has witnessed rise in research aimed at harnessing the potential of alginate-based hydrogels for developing delivery vehicles for drugs notably for cancer treatment. Moreover, alginate-based hydrogels exhibit bewildering potential in wide range of customization with respect to biological properties, thereby attracting investments in biomedical research by various companies in the alginate market for biomedical applications. The utilization of alginate in cardiovascular regeneration therapy is one of the potentially lucrative avenues that have emerged in recent years.
Alginate Market: Competition Landscape
The glaring health burden of cancer and increasing cancer-related deaths year after year have propelled R&D in novel drug delivery vehicles for cancer treatment. Biopharmaceutical companies are leveraging their understanding of the tumor biology and next-gen biosynthesis technologies for evaluating the potential of alginate as 3-D cell culture substrates for cancer treatment. This will likely open new frontiers in the alginate market.
In the past five years, a number of researchers from around the world have investigated the potential of alginate-PAMAM dendrimer (AG-G5) hybrid nanogel and alginate/liposome combination for enhancing drug delivery for breast and lung cancer. Another recent research investigated the potential of sodium alginate (NaAlg) in advanced wound dressings for severe burn injuries.
In recent years, the alginate market has witnessed a slew of companies expending on developing alginate based bioinks for 3D printing and alginate-based fabrics for textiles. Such research will pave the way for new applications in the near future.
Some of the key players in the alginate market are Shandong Jiejing Group Corporation, Algea, Ceamsa, KIMICA, Ingredients Solutions, Inc., and DuPont de Nemours, Inc.
Alginate Market: Regional Landscape
Developed nations notably in North America and Europe have witnessed considerate growth of potential revenues in the alginate market emerging from the demand for product in biomedical and biopolymer applications. Various countries notably the U.S. have seen the growing body of clinical trials that implicate alginate in cardiovascular diseases treatment. The prevalence of heart diseases and subsequent rise in need for cardiac regeneration therapies have cemented the prospects of the U.S. alginate market.
Meanwhile, Asia Pacific is also emerging as a hotbed of opportunities for players in the global alginate market. A vast body of research has been witnessed in harnessing the potential of alginate beads in engineering and regenerative medicines.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.